Eurofins Scientific SE: Transplant Genomics announces launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimise immunosuppression in liver transplant recipients
Regulatory News: Eurofins (Paris:ERF): Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide which is part of the Eurofins network of companies, is pleased to announce the commercial availability of TruGraf Liver, a blood-based gene expression test that provides guidance for optimisation of immunosuppression
Eurofins Scientific SE: Transplant Genomics announces launch of Trugraf Liver, the first and only non-invasive gene expression diagnostic test to optimise immunosuppression in liver transplant recipients
Regulatory News: Eurofins (Paris:ERF): Transplant Genomics (“TGI”), the transplant rejection diagnostics company committed to improving organ transplant outcomes worldwide which is part of the Eurofins network of companies, is pleased to announce the commercial availability of TruGraf Liver, a blood-based gene expression test that provides guidance for optimisation of immunosuppression